Publications by authors named "Ian M Dick"

Claim this Profile
B
BAP1 Loss by Immunohistochemistry Predicts Improved Survival to First-Line Platinum and Pemetrexed Chemotherapy for Patients With Pleural Mesothelioma: A Validation Study.
Amber Louw, Vasiliki Panou, Weronika Maria Szejniuk, Christos Meristoudis, Siaw Ming Chai, Ian M Dick

J Thorac Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Testing of Chemotherapy and Immune Checkpoint Blockade in Preclinical Cancer Models Identifies Additive Combinations.
Nicola Principe, Wayne J Aston, Danika E Hope, Caitlin M Tilsed, Scott A Fisher, Ian M Dick

Front Immunol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma.
Jenette Creaney, Ann-Marie Patch, Venkateswar Addala, Sophie A Sneddon, Katia Nones, Ian M Dick

Genome Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What's next in cancer immunotherapy? - The promise and challenges of neoantigen vaccination.
Alec J Redwood, Ian M Dick, Jenette Creaney, Bruce W S Robinson

Oncoimmunology· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophil-to-lymphocyte ratio in malignant pleural fluid: Prognostic significance.
Natalia Popowicz, Hui Min Cheah, Cynthia Gregory, Alina Miranda, Ian M Dick

PLoS One· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a CD8+ T-cell response to a predicted neoantigen in malignant mesothelioma.
Sophie Sneddon, Craig M Rive, Shaokang Ma, Ian M Dick, Richard J N Allcock

Oncoimmunology· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-treatment tumor neo-antigen responses in draining lymph nodes are infrequent but predict checkpoint blockade therapy outcome.
Shaokang Ma, Jonathan Chee, Vanessa S Fear, Catherine A Forbes, Louis Boon, Ian M Dick

Oncoimmunology· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Infiltrating Effector Memory Antigen-Specific CD8 T Cells Predict Response to Immune Checkpoint Therapy.
Nicola Principe, Joel Kidman, Siting Goh, Caitlin M Tilsed, Scott A Fisher, Ian M Dick

Front Immunol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination immune checkpoint blockade as an effective therapy for mesothelioma.
Vanessa S Fear, Caitlin Tilsed, Jonathan Chee, Catherine A Forbes, Thomas Casey, Ian M Dick

Oncoimmunology· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole exome sequencing of an asbestos-induced wild-type murine model of malignant mesothelioma.
Sophie Sneddon, Ann-Marie Patch, Ian M Dick, Stephen Kazakoff, John V Pearson

BMC Cancer· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Proteomic Analysis of the Malignant Mesothelioma Secretome Using iTRAQ.
Jenette Creaney, Ian M Dick, Justine S Leon, Bruce W S Robinson

Cancer Genomics Proteomics· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune response profiling of malignant pleural mesothelioma for diagnostic and prognostic biomarkers.
Jenette Creaney, Ian M Dick, A W Bill Musk, Nola J Olsen, Bruce W S Robinson

Biomarkers· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo.
David W Greening, Hong Ji, Maoshan Chen, Bruce W S Robinson, Ian M Dick

Sci Rep· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consistent gene expression profiles in MexTAg transgenic mouse and wild type mouse asbestos-induced mesothelioma.
Cleo Robinson, Ian M Dick, Michael J Wise, Andrew Holloway, Dileepa Diyagama

BMC Cancer· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pleural fluid mesothelin as an adjunct to the diagnosis of pleural malignant mesothelioma.
Jenette Creaney, Amanda Segal, Nola Olsen, Ian M Dick, A W Bill Musk

Dis Markers· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of mesothelin and fibulin-3 in pleural fluid and serum as markers in malignant mesothelioma.
Jenette Creaney, Ian M Dick, Bruce W Robinson

Curr Opin Pulm Med· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strong spontaneous tumor neoantigen responses induced by a natural human carcinogen.
Jenette Creaney, Shaokang Ma, Sophie A Sneddon, Michelle R Tourigny, Ian M Dick

Oncoimmunology· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Network analysis of immunotherapy-induced regressing tumours identifies novel synergistic drug combinations.
W Joost Lesterhuis, Catherine Rinaldi, Anya Jones, Esdy N Rozali, Ian M Dick

Sci Rep· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absence of germline mutations in BAP1 in sporadic cases of malignant mesothelioma.
Sophie Sneddon, Justine S Leon, Ian M Dick, Gemma Cadby, Nola Olsen

Gene· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of new biomarkers for malignant mesothelioma.
Jenette Creaney, Ian M Dick, Bruce W S Robinson

Curr Pulmonol Rep· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma.
Jenette Creaney, Ian M Dick, Tarek M Meniawy, Su Lyn Leong, Justine S Leon

Thorax· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the diagnostic accuracy of the MSLN gene products, mesothelin and megakaryocyte potentiating factor, as biomarkers for mesothelioma in pleural effusions and serum.
Jenette Creaney, Sophie Sneddon, Ian M Dick, Hanne Dare, Neil Boudville

Dis Markers· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pleural effusion hyaluronic acid as a prognostic marker in pleural malignant mesothelioma.
Jenette Creaney, Ian M Dick, Amanda Segal, Arthur W Musk, Bruce W S Robinson

Lung Cancer· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic effect of CTLA-4 blockade and cancer chemotherapy in the induction of anti-tumor immunity.
W Joost Lesterhuis, Joanne Salmons, Anna K Nowak, Esdy N Rozali, Andrea Khong, Ian M Dick

PLoS One· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does CA125 binding to mesothelin impact the detection of malignant mesothelioma?
Jenette Creaney, Ian M Dick, Hanne Dare, Yvonne Demelker, Anna K Nowak

Lung Cancer· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis